Novartis Venture Fund
Overview
Novartis Venture Fund is a corporate venture capital firm that invests in a wide array of companies working in biotechnology and biopharmaceuticals at various stages of growth and development across North America and Europe.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Sidewinder | Apr 2026 | Series B | Lead |
| Sidewinder Therapeutics | Apr 2026 | Series B | Lead |
| EpiBiologics | Jan 2026 | Series B | Co-investor |
| FoRx Therapeutics | Dec 2025 | Series A | Co-investor |
| Protego Biopharma | Dec 2025 | Series B | Lead |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Novartis Venture Fund based?
Novartis Venture Fund is headquartered in Basel, Switzerland.
When was Novartis Venture Fund founded?
Novartis Venture Fund was founded in 1996.
How many portfolio companies does Novartis Venture Fund have?
Novartis Venture Fund has 60 portfolio companies in Caplight's dataset.
What are some companies in Novartis Venture Fund's portfolio?
Recent investments visible on Caplight include Sidewinder, Sidewinder Therapeutics, EpiBiologics, FoRx Therapeutics, Protego Biopharma.
What was Novartis Venture Fund's most recent investment?
Novartis Venture Fund's most recent investment on Caplight was in Sidewinder in 2026.
What sectors does Novartis Venture Fund focus on?
Novartis Venture Fund focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech.
What company stages does Novartis Venture Fund focus on?
Novartis Venture Fund typically invests at the MultiStage stage.
What is Novartis Venture Fund's AUM?
Novartis Venture Fund's assets under management are estimated between $500.0M and $1.0B.